Browse Monoclonal antibodies topic

Subtopics (33)

• Adverse and side effects
• Analysis
• Cases
• Complications and side effects
• Conferences, meetings and seminars
• Contracts
• Dosage and administration
• Evaluation
• Foreign operations
• Genetic aspects
• Growth
• Health aspects
• Innovations
• Intellectual property
• Investigations
• Joint ventures
• Labeling
• Laws, regulations and rules
• Licensing agreements
• Marketing
• Physiological aspects
• Political aspects
• Product development
• Product information
• Production management
• Reports
• Research
• Rites, ceremonies and celebrations
• Safety and security measures
• Standards
• Technology application
• Tests, problems and exercises
• Usage

Articles

Title	Author	Type	Date	Words
Kyto Biopharma Inc. Announces High-Affinity Monoclonal Antibody to the Cellular Receptor for Transcobalamin (Vitamin B12).			Dec 3, 2009	988
New Data on Bristol-Myers Squibb Oncology Compounds to be Featured in Oral Presentations at 51st Annual Meeting of the American Society of Hematology.			Dec 2, 2009	1842
Treatment prolongs life.			Nov 27, 2009	107
LFB's Recombinant Anti-CD20 Monoclonal Antibody is Granted Orphan Drug Status in Europe for Chronic Lymphocytic Leukemia.			Nov 25, 2009	394
PX'Therapeutics to Open a New cGMP Biomanufacturing Facility.			Nov 23, 2009	327
Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic.			Nov 10, 2009	1003
MABCURE N.V. Signs Research Agreement With AZ Sint Lucas Hospital, Brugge, Belgium, to Conduct Preclinical Research on its Monoclonal Antibodies (Mabs) against Different Cancers.			Nov 4, 2009	569
FibroGen Announces New Research in Anti-CTGF and HIF-PHI Therapeutic Development Programs in Kidney Disease.		Clinical report	Nov 2, 2009	1551
Research and Markets: The Coagulation Market: New Product Development Opportunities And Business Expansion Strategies: France.			Nov 2, 2009	351
Major advance in human antibody therapy against deadly Nipah virus.			Nov 1, 2009	358
Celldex Therapeutics Presents Positive Clinical Data from Phase 1 Studies of Antibody-Based Cancer Vaccine Candidate, CDX-1307.			Oct 29, 2009	941
United States : Diagnostic Hybrids Announces FDA Clearance of D3[R] FastPointTM L-DFATM Influenza A/ Influenza B Virus Identification Kit.			Oct 28, 2009	333
United States : Precision Antibody Wins Contract to Develop 'Gold Standard' Antibodies as Part of National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative.			Oct 28, 2009	423
Diagnostic Hybrids Announces FDA Clearance of D3[R] FastPointTM L-DFATM Influenza A/ Influenza B Virus Identification Kit.			Oct 27, 2009	488
Idera Pharmaceuticals Announces Issuance of Patents Covering its Novel Toll-like Receptor-Targeted Compounds and Their Use.			Oct 26, 2009	795
ImmunoCellular Therapeutics Applies for Key Patent Relating to Novel Antigen Targets for Its Monoclonal Antibody Product Candidate.			Oct 19, 2009	786
Compugen and Bayer Schering Pharma to Collaborate on Compugen Discovered Oncology Target and Splice Variants.			Oct 13, 2009	1003
Trials testing safety of new antibody aimed at rabies virus launched in India.			Oct 12, 2009	373
United States : Peregrine Pharma lung cancer trial shows promise.			Oct 12, 2009	189
Theraclone and Zenyaku Kogyo Announce Influenza Antibody Alliance.			Oct 5, 2009	861
Trials testing safety of new antibody aimed at rabies virus launched in India.			Oct 5, 2009	373
The National Cancer Institute Selects Integral Molecular to Map Epitopes on Cancer Biomarkers using Shotgun Mutagenesis Mapping Technology.			Oct 1, 2009	325
The future is BRiTE.	Stebbing, Justin; Windsor, Alastair; Cohen, Richard	Clinical report	Oct 1, 2009	2135
15th Congress of the European Cancer Organization and the 34th European Society for Medical Oncology multidisciplinary congress: GI update.	Brown, Vanessa	Clinical report	Oct 1, 2009	1840
ImmunoCellular Therapeutics' Antibody Shows Promise in Detecting Pancreatic and Lung Cancer in Serum Test.			Sep 30, 2009	813
MabCure Inc. Produces Monoclonal Antibodies against Colorectal Cancer.			Sep 29, 2009	473
ImmunoCellular Therapeutics Announces Successful Humanization of Two Antibody Candidates.			Sep 23, 2009	701
Seattle Genetics Introduces Novel Technology for Empowering Antibodies.			Sep 22, 2009	630
Reportlinker Adds Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach.			Sep 21, 2009	976
Pancreatic and Colorectal Cancer Novel Antibody Developed from a Vaccine to Begin Phase I Trial.			Sep 17, 2009	423
Kenta Biotech Reports Phase IIa Data with Lead Candidate Panobacumab in Hospital-Acquired Pneumonia.			Sep 14, 2009	653
Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate.			Sep 14, 2009	960
Diagnostic HYBRIDS Announces FDA Clearance of D3[R] FastPointTM L-DFATM Respiratory Virus Identification Kit.			Sep 14, 2009	523
Research and Markets: The Japanese Coagulation Market, 2009-2018.			Sep 9, 2009	409
MabCure Inc. Featured in GEN (Genetic Engineering & Biotechnology News).			Sep 8, 2009	626
Laureate Pharma and Neoprobe Corporation Announce Manufacturing Alliance.			Sep 8, 2009	462
Research and Markets: The German Coagulation Market, 2009-2018.			Sep 8, 2009	411
Neutralizing antibodies that recognize HIV-1 envelope protein, lipids produced.			Sep 2, 2009	254
Diagnostic HYBRIDS Receives Special 510(k) Clearance for an Update to the D3 Ultra DFA Respiratory Virus Identification Kit Package Insert To Include Reactivity with Culture Isolates of 2009 H1N1.			Sep 2, 2009	457
United States : Diagnostic HYBRIDS Gets FDA Clearance for the Detection of Influenza A (H1N1)v Virus.			Sep 1, 2009	272
Mabcure Inc. Featured in Biotechnology Focus.			Aug 31, 2009	673
Finalists From Germany, France and Switzerland Nominated for The EUROPEAN BIOTECHNICA AWARD 2009.			Aug 25, 2009	687
Mabcure, Inc. Featured in BioWorld[R] Today.			Aug 25, 2009	692
Zacks Analyst Blog Highlights: News Corp., McGraw-Hill, NYSE Euronext, Thomson Reuters and Novartis.			Aug 25, 2009	703
United States : Crucell wins $41 million flu contract from US government.			Aug 18, 2009	222
Dr. Robert Shepard Joins Biothera as Chief Medical Officer.			Aug 12, 2009	609
First human receives new antibody aimed at neutralizing Hepatitis C virus.			Aug 7, 2009	484
Merriman Curhan Ford Acted as Co-Manager In Micromet's $80.5 Million Public Offering of Common Stock.			Aug 4, 2009	653
MabCure Inc. Provides Corporate Update.			Jul 27, 2009	950
OMT Announces a Breakthrough in the Development of a Novel Human Antibody Platform.			Jul 23, 2009	587
United Kingdom: Morphotek, Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies.			Jul 16, 2009	429
United States: Pfizer Reveals New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease.			Jul 16, 2009	400
Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease At ICAD Annual Meeting.			Jul 15, 2009	1448
Medarex to Receive Milestone Payment from FibroGen for the Initiation of a Phase 2 Study of FG-3019 in Patients with Diabetic Kidney Disease.			Jul 13, 2009	505
IAVI and Theraclone Expand HIV Antibody Discovery Collaboration.			Jul 6, 2009	741
India: Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis.			Jul 1, 2009	344
Changes in the activated cytotoxic suppressor T-lymphocytes in elderly patients with mediterranean spotted fever.	Gospodinova, Margarita D.; Nenova, Marina A.; Mileva, Sevda S.	Report	Jul 1, 2009	2906
ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 For Treatment of Small Cell Lung Cancer.			Jun 29, 2009	628
Xcellerex Announces Sale of FlexFactory[TM] Bioproduction Line to Crucell for Vaccine, Monoclonal Antibody Manufacturing Facility.			Jun 17, 2009	679
Eden Biodesign and Selexis Announce Continued Cooperation and a Global Joint-Marketing Collaboration.			Jun 17, 2009	667
Delphi Genetics Grants Licence to Sanofi Pasteur for Antibiotic-Free Manufacturing of Biological Products.			Jun 15, 2009	419
FibroGen Begins Enrollment of Phase 2 Study of FG-3019, Monoclonal Antibody Against CTGF, in Patients with Diabetic Kidney Disease.		Clinical report	Jun 15, 2009	839
Biosystems International Establishes Licensing Agreement with Lohocla Research Institute to Search for Novel Alcoholism Liver Disease Biomarkers.			Jun 11, 2009	441
OPKO Invests in Biotechnology Company Developing Human Antibody Library.			Jun 11, 2009	515
Biothera Launches Clinical Trial in KRAS-Mutated Colorectal Cancer Patients.			Jun 10, 2009	557
Seattle Genetics Presents Final Lintuzumab Phase I Clinical Data.			Jun 8, 2009	924
Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough.			Jun 8, 2009	355
Research and Markets: U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market From 2004 to 2014.			Jun 4, 2009	158
Alder Biopharmaceuticals Presents Results From Phase 1 Trial of ALD518 in Advanced Cancer at American Society of Clinical Oncology Annual Meeting.			Jun 1, 2009	486
United States: AbD Serotec and BBInternational Announce Cooperation and Co-Marketing Agreement.			May 22, 2009	464
Clinical Data, Inc. and Dana-Farber Cancer Institute Form Research Collaboration to Study Role of FCGR3A Gene Variants for Predicting Clinical Outcomes in Breast Cancer Treatment.			May 18, 2009	1303
Xencor to Present Phase 1 Data on XmAb[R]2513 Antibody for Lymphomas at the American Society of Clinical Oncology Annual Meeting.			May 15, 2009	352
Come and Meet the LFB Group at BIO 2009 in Atlanta (French Pavilion Hall B2 - Booth 1940).		Company overview	May 15, 2009	298
Accelerator Corporation Announces XORI Corporation.		Company overview	May 14, 2009	512
Biosystems International SAS Initiates Development of a Diagnostic Blood Test for Lung Cancer.			May 14, 2009	551
Goodwin Biotechnology Inc. to Exhibit at BIO International Convention, May 19 to 21, 2009 at Booth 5114.		Company overview	May 14, 2009	295
Receptor Logic, Inc. Launches New Website.		Website overview	May 13, 2009	456
Research and Markets: mAbs Journal - Order Now.		Clinical report	May 5, 2009	287
Clinical Data, Inc. Establishes Broad Research Collaboration with the University of Pittsburgh to Examine Role of FCGR3A Pathway for Predicting Clinical Outcomes in Cancer Treatment.			May 4, 2009	1236
Biotechnology project.			May 1, 2009	181
We have come some way in understanding the aetiology of inflammatory bowel disease, which has allowed advances in its management.	Pettengell, Keith E.	Disease/Disorder overview	May 1, 2009	3423
ImmunoCellular Therapeutics Granted Monoclonal Antibody Technology Patent.			Apr 29, 2009	628
BASi Expands Large Molecule Program.			Apr 28, 2009	288
MabCure Inc. Welcomes Dr. David S. Frank As New Member of the Board of Directors.			Apr 27, 2009	548
MONEY BRIEFS.			Apr 22, 2009	577
A*STAR Joins Forces with Swiss Company, Cytos, to Combat HFMD.			Apr 3, 2009	991
Monoclonal antibodies can be used as potent immune weapons against cancer.			Mar 22, 2009	599
Nonsteroidal medications for asthma management.	Gardenhire, Doug		Mar 1, 2009	1264
Peregrine Pharmaceuticals Awarded New United States Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio.			Mar 1, 2009	444
Human Genome Sciences and Morphotek, Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology.			Mar 1, 2009	817
Amgen Fremont Inc. obtains United States patent.			Mar 1, 2009	67
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1).	Wood, E.J.		Jun 1, 2008	452
Medimmune, Microsoft, and KSR: the United States Supreme Court in 2007 tips the balance in favor of innovation in patent cases, and thrice reverses the Federal Circuit.	Mota, Sue Ann		Jan 1, 2008	7577
Systemic lupus erythematosis.		Brief article	Sep 1, 2007	58
Agreements.			May 1, 2001	380
CME Questions.			Nov 1, 1999	128
Cyclooxygenase-2 and Colorectal Cancer.			Nov 1, 1999	1447
Abciximab enhances angio, may prevent procedure.			Aug 1, 1999	907
NEWS BRIEFS.			Feb 1, 1999	710
Prophylaxis with Monoclonal Antibody for RSV Infections in High-Risk Infants.			Nov 1, 1998	941